Nektar Therapeutics | NKTR - Ordinary Share Capital


Nektar Therapeutics reported $20.38M in Ordinary Share Capital for its fiscal quarter ending in December of 2025.





Ordinary Share Capital Change Date
Agios Pharmaceuticals USD 59.34M 892K Mar/2026
ALKERMES USD 166.46M 855K Mar/2026
Alterity Therapeutics Limited AUD 10.88B 10.66B Dec/2025
Amgen USD 540M 1000K Mar/2026
Baxter International USD 516.45M 2.17M Mar/2026
BioCryst Pharmaceuticals USD 213.06M 2.54M Dec/2025
Biogen USD 146.7M 200K Sep/2025
Bristol-Myers Squibb USD 2.04B 1.74B Sep/2025
Cara Therapeutics USD 9.38M 9.38M Sep/2025
Cipla INR 807.78M 17K Mar/2026
Dr.Reddys Laboratories INR 832.69M 176K Mar/2026
Eisai JPY 282.11M 0 Mar/2026
Eli Lilly USD 943.5M 3.33M Mar/2026
Esperion Therapeutics USD 245.22M 39.79M Dec/2025
Exelixis USD 253.7M 8.78M Mar/2026
Gilead Sciences USD 1.24B 1000K Mar/2026
GlaxoSmithKline GBP 4.05B 20.6M Mar/2026
Grifols EUR 680.58M 846.11K Dec/2025
Halozyme Therapeutics USD 118.52M 741K Mar/2026
Incyte USD 199.95M 1.49M Mar/2026
Ionis Pharmaceuticals USD 165.9M 3.93M Mar/2026
Ironwood Pharmaceuticals USD 160K 0 Dec/2024
Karyopharm Therapeutics USD 18.31M 18.3M Dec/2025
MacroGenics USD 63.32M 60K Dec/2025
Merck USD 2.47B 12.72M Dec/2025
Nektar Therapeutics USD 20.38M 20.36M Dec/2025
Neurocrine Biosciences USD 100.6M 500K Mar/2026
Novartis USD 1.91B 60K Mar/2026
Pfizer USD 5.7B 13M Mar/2026
Roche Holding CHF 795.62M 699.54K Dec/2025
Sarepta Therapeutics USD 105.57M 607K Mar/2026
Takeda JPY 1.58B 241K Mar/2026
Teva Pharmaceutical Industries USD 1.16B 16.72M Mar/2026
Xencor USD 74.06M 2.19M Mar/2026